Normunity logo

Normunity

Biotech company creating a new class of precision immuno-oncology medicines that enable normal immunity against cancer.

19 employees · est. 2021

VS
Parallel Bio logo

Parallel Bio

Using the immune system to cure disease.

27 employees · est. 2021 · Watertown, United States

Side-by-Side Comparison

Normunity Parallel Bio
Founded
2021 2021
Headquarters
Not tracked yet Watertown, United States
Employees
19 27
Industry
Biotechnology, Health and Wellness Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Series A Series A
Total Funding
$65.00M $25.43M
Funding Rounds
1 4
Services
Not tracked yet Human-first Drug Discovery, Precision Medicine Solutions, Foundation Model Development, Biological Atlas Creation
Target Customers
Not tracked yet Pharmaceutical Companies, Biotech Firms, Research Institutions, Healthcare Providers
Taxonomy
Precision Medicine, Immuno-oncology, Immune Normalizers, Cancer Research, Immune System, Drug Discovery, T-cell Therapy, Biotech Alliances, Yale School Of Medicine, Immune Disruption, Proprietary Discovery Platforms, Cancer Immunotherapy, Boston, West Haven Immune System Organoids, Drug Discovery, Immunotherapy Development, Computational Biology, Biotechnology Innovation, Human Health Insights, Disease Modeling, Organoid Technology, Therapeutic Discovery, Immune System Research, Personalized Medicine, Clinical Insights, Health Technology, Precision Medicine
Website
normunity.com parallel.bio
Normunity logo

About Normunity

Normunity is a biotech company founded in 2021 with a mission to develop innovative precision immuno-oncology medicines. The company, headquartered in Boston, Mass. and West Haven, Conn., is focused on creating a new class of medicines called immune normalizers, which aim to unlock the body's natura...

Parallel Bio logo

About Parallel Bio

Parallel Bio is a promising startup founded in 2021, aiming to revolutionize the field of drug discovery with its innovative technology. The company has developed a groundbreaking platform described as a human 'immune system in a dish', which holds the potential to significantly improve the efficien...

We will tell you when either one moves

BounceWatch watches Normunity and Parallel Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Normunity and Parallel Bio — by email.

Frequently Asked Questions

Normunity — Biotech company creating a new class of precision immuno-oncology medicines that enable normal immunity against cancer. . Parallel Bio — Using the immune system to cure disease.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Normunity has raised $65.00M while Parallel Bio has raised $25.43M.
Normunity and Parallel Bio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Normunity with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Normunity on 11 Sep 2024, and Parallel Bio on 4 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy